Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

We narrow down the most important market and consumer trends that could influence dairy product innovation in 2025.

A registered dietitian reveals nine food that work like weight-loss drugs, helping to curb cravings and suppress your ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

A new British study adds to growing evidence that GLP-1 diabetes meds might help curb problem drinking. Two clinical trials ...

GLP-1 medications, like Ozempic and Wegovy, mimic natural hormones in the body that regulate blood sugar and insulin levels. They’re used to treat type 2 diabetes and obesity. These drugs curb the ...

Nearly three-quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Over the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...